The mutation of tyrosine to asparagine at position 35 of Rheb [Rheb(Y35N)] in renal cell carcinoma has been reported to cause mTORC1 hyperactivation by increasing the resistance to TSC2 GAP activity, resulting in the hyperproliferation of tumor cells [129]. Here, RHEB is linked to renal cell carcinoma.